Funded Projects › H2020
PRIMAGE · PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers
PRIMAGE proposes a cloud-based platform to support decision making in the clinical management of malignant solid tumours, offering predictive tools to assist diagnosis, prognosis, therapies choice and treatment follow up, based on the use of novel imaging biomarkers, in-silico tumour growth simulation, advanced visualisation of predictions with weighted confidence scores and machine-learning based translation of this knowledge into predictors for the most relevant, disease-specific, Clinical End Points.PRIMAGE implements a hybrid cloud model, comprising the of use of open public cloud (based on EOSC services) and private clouds, enabling use by the scientific community (facilitating reuse of de-identified clinical curated data in Open Science) and also suitable for future commercial exploitation.The proposed data infrastructures, imaging biomarkers and models for in-silico medicine research will be validated in the application context of two paediatric cancers, Neuroblastoma (NB, the most frequent solid cancer of early childhood) and the Diffuse Intrinsic Pontine Glioma (DIPG, the leading cause of brain tumour-related death in children). These two paediatric cancers are relevant validation cases given their representativeness of cancer disease, and their high societal impact, as they affect the most vulnerable and loved family members.The European Society for Paediatric Oncology, two Imaging Biobanks and three of the most prominent European Paediatric oncology units are partners in this project, making retrospective clinical data (imaging, clinical, molecular and genetics) registries accessible to PRIMAGE, for training of machine learning algorithms and testing of the in-silico tools´ performance. Solutions to streamline and secure the data pseudonymisation, extraction, structuring, quality control and storage processes, will be implemented and validated also for use on prospective data, contributing European shared data infrastructures.
Consortium · 17 organisations
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA
ES · €1,243,342
CHEMOTARGETS SL
ES · €661,326
QUIBIM SOCIEDAD LIMITADA
ES · €919,064
AKADEMIA GORNICZO-HUTNICZA IM. STANISLAWA STASZICA W KRAKOWIE
PL · €538,566
KLINIKUM DER UNIVERSITAET ZU KOELN
DE · €751,375
THE UNIVERSITY OF SHEFFIELD
UK · €616,680
UNIVERSIDAD DE ZARAGOZA
ES · €796,184
ST. ANNA KINDERKREBSFORSCHUNG GMBH
AT · €842,512
UNIVERSITA DI PISA
IT · €637,564
ST ANNA KINDERKREBSFORSCHUNG VEREIN
AT
ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
IT · €192,314
UNIVERSITAT KONSTANZ
DE · €756,066
UNIVERSITAT POLITECNICA DE VALENCIA
ES · €457,126
SIOP EUROPE
BE · €323,364
BC PLATFORMS
FR · €384,806
ANSYS FRANCE SAS
FR · €810,874
MATICAL INNOVATION SL
ES · €380,756
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.